|
Product complaint # (b)(4) this report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information was requested, and the following was obtained: syringe separation occurs during the suturing of a uterus using sxpp1a405 during laparoscopic uterine fibroid surgery.The stitching is completed with the replacement of the new stitch.When did the alleged deficiency occur (removal from package / during handling prior to use on patient/ during passage through tissue / during tying / post-op)? if different, please explain.During passage through tissue.H3 investigation summary: the product was returned to ethicon for evaluation.One empty foil, one empty labeled winding former, one needle-suture piece and one suture piece were received for analysis.Product code sxpp1a405.During visual inspection of the returned needle-suture piece, the swage and attachment area were observed as expected; however, the body of the needle exhibited noticeable bending, along with significant crimping marks that are consistent with those caused by a surgical instrument.The suture piece was noted to be still attached to the barrel hole of the needles.Overall, no needle pull-off was observed.The sutures were examined, and the extremes of the sutures were noted to be cut and damaged (crushed) on the suture surface and the extremes likely by a surgical instrument.Furthermore, body fluids were noted along the length of the suture.The product code sxpp1a405 contains an absorbable suture.Since the samples were received open, the functional test could not be performed due to undetermined exposure to the environment.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.The event described could not be confirmed as no issues related to pull off - suture needle were noted.Although no product defect was identified, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the laboratory analysis.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.
|
|
Product complaint #(b)(4).Date sent to the fda: 5/1/2026.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested, the following was obtained: procedure name should be laparoscopic myomectomy for uterine fibroids.
|